BR0204228A - Métodos para melhorar os sintomas de uma psicose e de esquizofrenia e para triar moléculas de teste, e, composto orgânico - Google Patents
Métodos para melhorar os sintomas de uma psicose e de esquizofrenia e para triar moléculas de teste, e, composto orgânicoInfo
- Publication number
- BR0204228A BR0204228A BR0204228-2A BR0204228A BR0204228A BR 0204228 A BR0204228 A BR 0204228A BR 0204228 A BR0204228 A BR 0204228A BR 0204228 A BR0204228 A BR 0204228A
- Authority
- BR
- Brazil
- Prior art keywords
- psychosis
- schizophrenia
- symptoms
- methods
- organic compound
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Abstract
"MéTODOS PARA MELHORAR OS SINTOMAS DE UMA PSICOSE E DE ESQUIZOFRENIA E PARA TRIAR MOLéCULAS DE TESTE, E, COMPOSTO ORGâNICO". Método para o tratamento de sintomas de uma psicose especialmente para o tratamento de esquizofrenia. O tratamento consiste de administração oral repetida de um flavonóide. Quercetina é efetivo, assim como vários outros flavonóides incluindo flavonas como luteolina. Os flavonóides parecem operar por redução da atividade de canais de íons hSKCa3.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27008701P | 2001-02-20 | 2001-02-20 | |
PCT/US2002/005688 WO2002066032A1 (en) | 2001-02-20 | 2002-02-20 | Treatment of schizophrenia |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0204228A true BR0204228A (pt) | 2004-06-22 |
Family
ID=23029855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0204228-2A BR0204228A (pt) | 2001-02-20 | 2002-02-20 | Métodos para melhorar os sintomas de uma psicose e de esquizofrenia e para triar moléculas de teste, e, composto orgânico |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1377286A1 (pt) |
BR (1) | BR0204228A (pt) |
WO (1) | WO2002066032A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7935714B2 (en) * | 2004-05-18 | 2011-05-03 | Bright Future Pharmaceutical Laboratories | Compositions for sleeping disorders |
CA2595486A1 (en) * | 2005-01-20 | 2006-07-27 | Sirtris Pharmaceuticals, Inc. | Use of sirtuin-activating compounds for treating flushing and drug induced weight gain |
DE502005002104D1 (de) * | 2005-05-13 | 2008-01-10 | Mewicon Med Wiss Beratung Gmbh | Hesperidin zur Behandlung von Epilepsie |
CN101091706B (zh) * | 2006-06-23 | 2011-05-04 | 和泓生物技术(上海)有限公司 | 多巴胺转运蛋白激动剂及其用途 |
BRPI0801239A2 (pt) * | 2008-04-01 | 2009-11-17 | Ache Lab Farmaceuticos Sa | uso de um ou mais benzopiranonas, composição farmacêutica e método de prevenção ou tratamento de doenças, disfunções e distúrbios associados a monoamino oxidase |
WO2010062681A2 (en) * | 2008-10-30 | 2010-06-03 | University Of South Florida | Luteolin and diosmin/diosmetin as novel stat3 inhibitors for treating autism |
US20120029066A1 (en) * | 2010-07-30 | 2012-02-02 | Taipei Medical University | Use of flavones for treating psychiatric disorders with sensorimotor gating deficits |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU556817B2 (en) * | 1982-02-03 | 1986-11-20 | Efamol Limited | Topical application of a lithium salt and dihomo-alpha- linolenic acid |
JPH0798752B2 (ja) * | 1991-08-09 | 1995-10-25 | 株式会社ツムラ | β−グルクロニダーゼ阻害剤 |
US6083526A (en) * | 1997-05-22 | 2000-07-04 | Gorbach; Sherwood L. | Use of isoflavonoids in the treatment or prevention of postpartum depression |
WO1999021005A2 (en) * | 1997-10-23 | 1999-04-29 | Pharmaprint, Inc. | Pharmaceutical grade st. john's wort |
US6030621A (en) * | 1998-03-19 | 2000-02-29 | De Long; Xie | Ginkgo biloba composition, method to prepare the same and uses thereof |
KR100407399B1 (ko) * | 2000-08-22 | 2003-11-28 | 주식회사 뉴로넥스 | 세로토닌 n-아세틸트란스퍼라제의 활성 억제제 |
-
2002
- 2002-02-20 BR BR0204228-2A patent/BR0204228A/pt not_active IP Right Cessation
- 2002-02-20 WO PCT/US2002/005688 patent/WO2002066032A1/en not_active Application Discontinuation
- 2002-02-20 EP EP02723237A patent/EP1377286A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1377286A1 (en) | 2004-01-07 |
WO2002066032A1 (en) | 2002-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTC1620113I2 (lt) | Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui | |
NO20044259L (no) | Topiske farmasoytiske sammensetninger inneholdende proantocyanidiner for behandling av dermatitt | |
BR0012450A (pt) | Benzimidazóis substituìdos | |
UY29112A1 (es) | Derivados de pirazol condensado, su preparacion y su aplicacion terapeutica | |
AR022469A1 (es) | Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevas sustancias | |
GB0222495D0 (en) | Compounds | |
BRPI0515483A (pt) | derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase | |
PA8493701A1 (es) | Compuestos para tratar la obesidad | |
BRPI0416752A (pt) | composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica | |
NO20050718L (no) | Topikal behandling av hudsykdommer | |
ES2328496T3 (es) | Compuestos de 1,4,8-triaza-espiro(4,5)decan-2-ona sustituidos. | |
NO20061236L (no) | Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton | |
ATE336996T1 (de) | Verwendung von flavonoid-derivaten zur behandlung von atopischem ekzem | |
BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
HK1085122A1 (en) | Method of stimulating hair growth using benzopyrans | |
CR9079A (es) | Nonadepsipeptidos acilados como derivados de lisobactina | |
BR0204228A (pt) | Métodos para melhorar os sintomas de uma psicose e de esquizofrenia e para triar moléculas de teste, e, composto orgânico | |
WO2006136428A3 (en) | Method and composition to treat skin ulcers | |
DK1846430T3 (da) | Hidtil ukendte makrolider | |
NO20052172D0 (no) | 4-aminopiperidinderivater, fremgangsmate for deres fremstilling og deres anvendelse som medikamenter | |
BR0308567A (pt) | derivados de glicosìdeo e glicosìdeo de ortoéster de apomorfina, análogos, e seus usos | |
BR0211635A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de um indivìduo sofrendo de ou propenso à doença de alzheimer | |
NO20030802L (no) | Aminoalkoksybenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte for deres fremstilling og preparater inneholdende de samme | |
NO20054346L (no) | Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander | |
DK1448544T3 (da) | Substituerede benzopyraner som selektive estrogenreceptor-beta-agonister |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE 6A., 7A., E 8A. ANUIDADES. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2055 DE 25/05/2010. |
|
B15K | Others concerning applications: alteration of classification |
Ipc: G01N 33/68 (2006.01), A61K 31/335 (2006.01), A61K |